MediWound

+$0.22 (+5.67%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MediWound and other ETFs, options, and stocks.

About MDWD

MediWound Ltd. is a biopharmaceutical company engaging in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid.

CEO
Sharon Malka
Employees
75
Headquarters
Yavne, HaMerkaz
Founded
2000

MDWD Key Statistics

Market Cap
111.71M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
757.53K
High Today
$4.10
Low Today
$3.85
Open Price
$3.89
Volume
118.38K
52 Week High
$6.22
52 Week Low
$2.90

MDWD News

MarketWatchJul 26

MediWound Begins Phase 1/2 Study for Skin-Cancer Treatment

By Chris Wack MediWound Ltd. said it has begun its Phase 1/2 study of MW005 for the treatment of low-risk basal cell carcinoma. The company is also conducting

MDWD Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure